• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿义马林和奎尼丁在小鼠体内的药代动力学及器官分布

The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.

作者信息

Iven H

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):43-50. doi: 10.1007/BF00510985.

DOI:10.1007/BF00510985
PMID:882146
Abstract

After i.v. infusion into mice (lasting 10 s) the time courses of ajmaline and quinidine concentrations in blood, heart, lung, liver, and brain were studied. The drugs were assayed by a spectrofluorophotometric procedure. Blood concentration data obtained were fitted graphically and calculations were performed in accordance with an open two compartment model. Blood kinetic data were very similar for both alkaloids. A rapid distribution phase with a t0.5alpha of 3.0 min for ajmaline and 2.5 min for quindine was followed by a disposition phase with a t0.5beta of 16 min for ajmaline and 20 min for quinidine. High tissue accumulation of both alkaloids was found in lung, liver, and heart and this is also reflected by the volume of distribution Vdbeta, which was 136 ml for ajmaline and 116 ml for quinidine (body weight of the mice = 31 g). With equilibrium dialysis a 62% binding of ajmaline and a 77% binding of quinidine to mouse blood constituents was found. Both drugs were highly metabolized since only 5% of a given dose was excreted unchanged in the urine.

摘要

将阿义马林和奎尼丁静脉注射到小鼠体内(持续10秒)后,研究了它们在血液、心脏、肺、肝脏和大脑中的浓度随时间的变化过程。采用荧光分光光度法对药物进行测定。所获得的血液浓度数据通过图形拟合,并根据开放二室模型进行计算。两种生物碱的血液动力学数据非常相似。阿义马林的快速分布相t0.5α为3.0分钟,奎尼丁为2.5分钟,随后是消除相,阿义马林的t0.5β为16分钟,奎尼丁为20分钟。在肺、肝脏和心脏中发现两种生物碱都有较高的组织蓄积,这也反映在分布容积Vdbeta上,阿义马林为136 ml,奎尼丁为116 ml(小鼠体重=31 g)。通过平衡透析发现,阿义马林与小鼠血液成分的结合率为62%,奎尼丁为77%。两种药物都有很高的代谢率,因为给定剂量中只有5%以原形从尿液中排泄。

相似文献

1
The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.阿义马林和奎尼丁在小鼠体内的药代动力学及器官分布
Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):43-50. doi: 10.1007/BF00510985.
2
Mechanisms of pharmacokinetic interaction between ajmaline and quinidine in rats.大鼠中阿义马林与奎尼丁之间的药代动力学相互作用机制。
J Pharmacobiodyn. 1986 Apr;9(4):347-51. doi: 10.1248/bpb1978.9.347.
3
Metabolic disposition of ajmaline.阿吗灵的代谢情况
Eur J Drug Metab Pharmacokinet. 1989 Oct-Dec;14(4):309-16. doi: 10.1007/BF03190117.
4
Quinidine-induced rise in ajmaline plasma concentration.奎尼丁引起阿义马林血浆浓度升高。
J Pharm Pharmacol. 1984 Mar;36(3):202-4. doi: 10.1111/j.2042-7158.1984.tb06942.x.
5
Disposition kinetics of quinidine.
Clin Pharmacol Ther. 1976 Jan;19(1):30-6. doi: 10.1002/cpt197619130.
6
[On the antifibrillary effect on the heart of ajmaline, bromo-ajmaline, quindine and novocaine amide].[关于阿吗灵、溴阿吗灵、奎尼丁和奴夫卡因酰胺对心脏的抗纤颤作用]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;243:519-27.
7
Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.比格犬中阿义马林处置动力学及药理反应
J Pharmacokinet Biopharm. 1987 Feb;15(1):39-55. doi: 10.1007/BF01062938.
8
Pharmacokinetics of quinidine and three of its metabolites in man.
J Pharmacokinet Biopharm. 1984 Feb;12(1):1-21. doi: 10.1007/BF01063608.
9
Effects of cimetidine on quinidine distribution in rats.西咪替丁对奎尼丁在大鼠体内分布的影响。
J Pharmacobiodyn. 1987 Dec;10(12):719-26. doi: 10.1248/bpb1978.10.719.
10
Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
Acta Pharmacol Toxicol (Copenh). 1977 Aug;41(2):161-76. doi: 10.1111/j.1600-0773.1977.tb02136.x.

引用本文的文献

1
Carrier-mediated uptake of clonidine in cultured human lung cells.载介导的可乐定在培养的人肺细胞中的摄取。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):361-369. doi: 10.1007/s00210-018-1467-7. Epub 2018 Jan 19.
2
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.种间尺度转换与人体清除率预测:小分子药物与大分子药物的比较
Xenobiotica. 2011 Nov;41(11):972-87. doi: 10.3109/00498254.2011.598582. Epub 2011 Sep 5.
3
Pharmacokinetics and electrophysiological effects of intravenous ajmaline.

本文引用的文献

1
[Quantities and rates of excretion of the Rauwolfia alkaloid ajmaline following different methods of administration].[不同给药方法后萝芙木生物碱阿吗灵的排泄量及排泄率]
Arzneimittelforschung. 1961 Dec;11:1100-2.
2
[Behavior of the serum level after intravenous injections of ajmaline].[静脉注射阿义马林后血清水平的变化]
Klin Wochenschr. 1962 Feb 1;40:149-51. doi: 10.1007/BF01482017.
3
SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.与奎尼丁作为抗心律失常原型药物作用相关的一些细胞和代谢方面的考量
静脉注射阿义马林的药代动力学和电生理效应
Clin Pharmacokinet. 1993 Nov;25(5):408-14. doi: 10.2165/00003088-199325050-00006.
4
Prediction of the volumes of distribution of basic drugs in humans based on data from animals.基于动物数据预测碱性药物在人体中的分布容积。
J Pharmacokinet Biopharm. 1984 Dec;12(6):587-96. doi: 10.1007/BF01059554.
5
Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.基于生理药代动力学对大鼠体内奎尼丁非线性组织分布的分析。
J Pharmacokinet Biopharm. 1985 Aug;13(4):425-40. doi: 10.1007/BF01061478.
6
Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.比格犬中阿义马林处置动力学及药理反应
J Pharmacokinet Biopharm. 1987 Feb;15(1):39-55. doi: 10.1007/BF01062938.
7
Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.大鼠缺血及再灌注诱导心律失常的区域性心肌阿义马林浓度及抗心律失常活性
Br J Pharmacol. 1988 Apr;93(4):827-32. doi: 10.1111/j.1476-5381.1988.tb11468.x.
8
Role of phosphatidylserine in the cellular and subcellular lung distribution of quinidine in rats.磷脂酰丝氨酸在奎尼丁于大鼠肺组织细胞及亚细胞水平分布中的作用。
Pharm Res. 1988 Apr;5(4):209-13. doi: 10.1023/a:1015985511653.
9
Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism.阿吗灵在甲状腺功能亢进大鼠体内的药代动力学及变时性活性
Br J Pharmacol. 1989 Jan;96(1):163-9. doi: 10.1111/j.1476-5381.1989.tb11796.x.
10
Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.慢性肾衰竭患者的阿义马林试验。一项药代动力学和药效学研究。
Clin Pharmacokinet. 1991 Aug;21(2):150-4. doi: 10.2165/00003088-199121020-00005.
Am J Med. 1964 Nov;37:685-99. doi: 10.1016/0002-9343(64)90018-x.
4
QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.血浆中奎尼丁的定量测定
Scand J Clin Lab Invest. 1963;15:553-6. doi: 10.1080/00365516309079786.
5
[On the mechanism of action of ajmaline].[关于阿吗灵的作用机制]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1961;242:17-23.
6
Quinidine: arterial, venous, coronary sinus and myocardial concentrations.奎尼丁:动脉、静脉、冠状窦及心肌浓度。
J Clin Invest. 1961 Jan;40(1):60-5. doi: 10.1172/JCI104237.
7
Some quantitative aspects of the binding of quinidine and related quinoline compounds by human serum albumin.奎尼丁及相关喹啉化合物与人血清白蛋白结合的一些定量方面
J Clin Invest. 1961 Mar;40(3):509-16. doi: 10.1172/JCI104278.
8
[Clinical studies on the mechanism of action of the Rauwolfia alkaloid ajmaline in cardiac rhythm disorders especially extrasystole].
Med Klin. 1959 Mar 6;54(10):409-16.
9
Some physico-chemical factors in drug action.药物作用中的一些物理化学因素。
J Pharm Pharmacol. 1957 Jun;9(6):345-80. doi: 10.1111/j.2042-7158.1957.tb12289.x.
10
The metabolic fate of orally administered quinidine gluconate in humans.口服葡萄糖酸奎尼丁在人体内的代谢转归。
Biochem Pharmacol. 1969 Aug;18(8):8145-60. doi: 10.1016/0006-2952(69)90280-9.